POSB258 Evaluation of the Current Impact of Indirect Treatment Comparisons (ITCS) to Support Health Technology Assessments (HTAS) in Rare Diseases

Abstract

Authors

M Musat A Forsythe S Harricharan

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×